Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:15 AM ET 8-K
Clinical Trial Data enGene Therapeutics Inc. ENGN

enGene Therapeutics Clinical Trial Data

enGene Therapeutics announced results from the pivotal Cohort 1 of its Phase 2 LEGEND trial evaluating detalimogene in BCG-unresponsive non-muscle invasive bladder cancer. The company also reached alignment with the FDA on key components for its planned Biologics License Application (BLA) submission.

Counterparty
FDA
6:14 AM ET Form 4
Insider Buying Mach Natural Resources LP MNR

Mach Natural Resources Insider Tom L. Ward Buys $1.01M of Stock

Tom L. Ward bought 110,000 shares of Mach Natural Resources LP at $9.13 to $9.21 a share (average $9.17) in 2 transactions, worth $1.01M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 13,577,452 (+0.4%).

Value
$1.01M
Shares
110,000
Average price
$9.17
Holding change
+0.4%
Trade date
Nov 9, 2026 to Nov 10, 2026
6:14 AM ET 8-K
Capital Raise Addentax Group Corp. ATXG

Addentax Group Capital Raise of $1.5M

Addentax Group Corp. entered into a private placement agreement with investor Chan Kai Fung to sell 312,500 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for general corporate purposes and working capital.

Value
$1.5M
Counterparty
Chan Kai Fung
6:14 AM ET 8-K
Other 8-K Filing CXJ Group CO., Ltd ECXJ

CXJ Group CO Other 8-K Filing

CXJ Group Co., Limited announced that J & S Associate PLT. resigned as its independent registered public accounting firm on November 4, 2026. The company subsequently appointed WSJ and Partners as its new auditor for the fiscal year ending May 31, 2027, effective November 5, 2026.

Counterparty
WSJ and Partners
6:14 AM ET 8-K
Divestiture Vylor Inc. VYLR

Vylor Divestiture

Vylor Inc. reported the completion of its separation from Corteva, Inc. into an independent, publicly traded company via a tax-free spin-off. The transaction was executed through a pro rata dividend in-kind of Vylor common stock to Corteva stockholders, with Vylor's shares commencing trading on the NYSE under the ticker 'VYLR' on October 1, 2026.

6:12 AM ET 8-K
Financial Results Yeti Holdings, Inc. YETI

Yeti Holdings Financial Results

YETI reported third quarter 2026 financial results with net sales increasing 4% to $509.4 million and adjusted EPS rising 49% to $0.91. The company updated its full-year 2026 outlook, narrowing adjusted sales growth to approximately 6% while maintaining adjusted operating margin targets despite a cautious consumer environment.

Term
Q3 2026

“YETI delivered Q3 adjusted sales growth of more than 6%, reflecting the increasing breadth and balance of our growing global business, with Drinkware up 8% and international up 19%. Strong operating discipline drove margin expansion, with profits growing significantly faster than sales. Our continued strong free cash flow generation supported our long-term growth plans while also returning capital through share repurchases.”

Matt Reintjes, Chair of the Board, President, and Chief Executive Officer

“This performance demonstrates continued progress against our Investor Day “Built for the Wild” strategy. It reflects the dedication of our teams and partners, and the multi-year investments we have made across brand, innovation, and global capabilities. Together, these results reinforce the strength of the financial model we outlined. While demand was uneven at times during the quarter, particularly in the US and Canadian markets, the expanding diversity of our products, channels, and geographies strongly supported our overall performance.”

Matt Reintjes, Chair of the Board, President, and Chief Executive Officer
6:12 AM ET 8-K
Financial Results Rockwell Medical, Inc. RMTI

Rockwell Medical Financial Results

Rockwell Medical reported third quarter 2026 net sales of $19.1 million, a 20% increase year-over-year, driven by higher volumes from existing and new customers. The company highlighted its pending transformational acquisition of Vantive's hemodialysis business, which is projected to generate annual revenue between $400 million and $450 million.

Term
Q3 2026

“We have maintained solid upward momentum across our business, driven by robust market demand and disciplined execution. Our third quarter 2026 net sales grew 20% year-over-year, reflecting strong customer adoption and market validation of our products.”

Mark Strobeck, Ph.D., President and Chief Executive Officer
6:12 AM ET 10-Q
Financial Results National Vision Holdings, Inc. EYE

National Vision Holdings Q3 2026 Results: Net Income $19.2M, Up 469.0% YoY

National Vision Holdings, Inc. filed its Form 10-Q for the period ending October 30, 2026, reporting 78,067,119 shares of common stock outstanding. The filing highlights strategic initiatives including ERP and CRM updates, while noting risks related to vision care professional recruitment and macroeconomic impacts on consumer spending.

Key figure
Net income $19.2M · +469.0% YoY
6:12 AM ET 8-K
Reverse Stock Split GeoVax Labs, Inc. GOVX

GeoVax Labs Reverse Stock Split

GeoVax Labs, Inc. filed a Certificate of Amendment to its Certificate of Incorporation to effect a 1-for-24 reverse stock split of its common stock. The split automatically combines every 24 shares of issued and outstanding common stock into one share, with fractional shares rounded up to the nearest whole number. The action is intended to consolidate the number of outstanding shares without changing the proportional ownership interest of stockholders.

6:10 AM ET 6-K
Financial Results Pelagos Insurance Capital Ltd PLGO

Pelagos Insurance Capital Q3 2026 Results: Net Income $61.7M, Down 52.7% YoY

Pelagos Insurance Capital reported net income growth for the nine months ended September 30, 2026, with gross premiums written increasing to $3,977.0 million from $3,739.4 million in the prior year period. However, total shareholders' equity decreased to $2,141.2 million as of September 30, 2026, compared to $2,399.6 million at year-end 2025, primarily driven by a reduction in additional paid-in capital.

Key figure
Net income $61.7M · -52.7% YoY
6:10 AM ET Form 4
Insider Buying Neonc Technologies Holdings, Inc. NTHI

Neonc Technologies Holdings CEO, President Amir F. Heshmatpour Buys $294K of Stock

Amir F. Heshmatpour, CEO, President, bought 70,000 shares of Neonc Technologies Holdings, Inc. at $4.00 to $4.49 a share (average $4.21) in 3 transactions, worth $294K in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 3,333,000 (+0.3%).

Value
$294K
Shares
70,000
Average price
$4.21
Role
CEO, President
Holding change
+0.3%
Trade date
Nov 10, 2026 to Nov 11, 2026
6:10 AM ET 8-K
Business Update Murphy Oil Corp MUR

Murphy Oil Business Update

Murphy Oil Corporation announced its entry into the Eastern Mediterranean through the award of six exploration licenses in Zone G offshore Israel, where it will serve as operator with a 50% interest. Additionally, the company executed four production sharing contracts for offshore blocks in Cameroon, including the Elombo, Etinde Exploration, Ntem, and Tilapia blocks.

Counterparty
Government of Israel
6:10 AM ET 8-K
Financial Results Marimed Inc. MRMD

Marimed Financial Results

MariMed Inc. reported record third-quarter 2026 revenue of $44.2 million, a year-over-year increase driven by growth in both wholesale and retail segments. Despite the revenue growth, the company reported a GAAP net loss of $3.5 million as it continues to execute its 'Expand the Brand' strategy and navigate broader market conditions.

Term
Q3 2026

“I’m pleased to report that the momentum we built earlier this year extended through the third quarter. Wholesale and retail revenue both grew sequentially and year over year, and total revenue reached another record for MariMed. Adjusted EBITDA improved from the prior quarter, and we again generated positive cash flow from operations, ending the quarter in our strongest position in more than two years.”

Jon Levine, MariMed’s Chief Executive Officer
6:10 AM ET Form 4
Insider Selling Ibotta, Inc. IBTA

Ibotta 10% Owner KDT Ibotta Holdings LLC Sells $11.7M of Stock

KDT Ibotta Holdings LLC, 10% Owner, sold 200,000 shares of Ibotta, Inc. at $58.47 to $58.72 a share (average $58.59) in 2 transactions, worth $11.7M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 3,289,129 (-3.0%).

Value
$11.7M
Shares
200,000
Average price
$58.59
Role
10% Owner
Holding change
-3.0%
Trade date
Nov 9, 2026 to Nov 10, 2026
6:09 AM ET 8-K
Financial Results Tetra Tech Inc TTEK

Tetra Tech Financial Results

Tetra Tech reported record fourth quarter and fiscal year 2026 results, with Q4 revenue reaching $1.34 billion and adjusted EPS of $0.49. The company also announced a 13% year-over-year increase in backlog to $4.67 billion and declared a quarterly cash dividend of $0.072 per share.

Term
Q4 2026

“We completed fiscal year 2026 with a strong fourth quarter driven by our global commercial and government businesses. We continue to see increasing demand for our differentiated Leading with Science® technical services for water and environmental programs, including digital automation for associated facilities.”

Roger Argus, Chief Executive Officer

“In fiscal year 2026, we continued to increase our profit margins with 90 basis points of EBITDA margin expansion from fiscal year 2025. The strength of our balance sheet and consistent cash flow generation enabled us to return $115 million to our stockholders through dividends and share repurchases during the year.”

Steve Burdick, Chief Financial Officer
6:09 AM ET 8-K
M&A Deal Marinemax Inc HZO

Marinemax M&A Deal with Safe Harbor Marinas, LLC

MarineMax shareholders approved the previously announced merger agreement with affiliates of Safe Harbor Marinas, a portfolio company of Blackstone Infrastructure Partners. At a special meeting held on November 11, 2026, over 73% of outstanding shares were represented, with the vast majority voting in favor of the acquisition that will take the company private.

Counterparty
Safe Harbor Marinas, LLC
6:08 AM ET Form 4
Insider Buying San Juan Basin Royalty Trust SJT

San Juan Basin Royalty Trust Insider Eric L. Oliver Buys $1.4M of Stock

Eric L. Oliver bought 352,364 shares of San Juan Basin Royalty Trust at $3.56 to $4.14 a share (average $3.99) in 2 transactions, worth $1.4M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 4,942,794 (+5.5%).

Value
$1.4M
Shares
352,364
Average price
$3.99
Holding change
+5.5%
Trade date
Nov 9, 2026 to Nov 10, 2026
6:08 AM ET 10-Q
Financial Results Investcorp Credit Management BDC, Inc. ICMB ▶ Call

Investcorp Credit Management BDC Q3 2026 Results: Net Loss of $4.76M, Loss Widens

Investcorp Credit Management BDC, Inc. reported a net decrease in net assets resulting from operations of $14.5 million for the nine months ended September 30, 2026, driven by significant unrealized depreciation on investments. The company's Net Asset Value (NAV) per share declined from $4.03 at the end of 2025 to $3.02 as of September 30, 2026.

Key figure
Net loss $4.76M
6:08 AM ET 8-K/A
M&A Deal Lisata Therapeutics, Inc. LSTA

Lisata Therapeutics M&A Deal with Marea Therapeutics, Inc.

Lisata Therapeutics filed an amendment to its previous 8-K to provide required audited financial statements and pro forma financial information following its completed acquisition of Marea Therapeutics, Inc. The filing includes combined financial statements for Marea and M2 Therapeutics for the years 2024 and 2025, as well as interim 2026 data.

Counterparty
Marea Therapeutics, Inc.
6:08 AM ET 8-K
Loan & Debt WEX Inc. WEX

WEX $900M Debt Financing with Bank of America, N.A.

WEX Inc. entered into the Eighth Amendment to its Amended and Restated Credit Agreement, extending the maturity of its revolving credit facility and tranche A term loans to November 6, 2031. The amendment increases the revolving credit facility from $1.6 billion to $1.7 billion and increases the tranche A term loan facility from $787.5 million to $900 million while repricing interest margins based on leverage ratios.

Value
$900M
Counterparty
Bank of America, N.A.
Term
through Nov 2031
6:08 AM ET 8-K
Deal Termination International Money Express, Inc. IMXI

International Money Express Deal Termination with The Western Union Company

The Western Union Company has issued a notice to terminate its previously announced merger agreement with International Money Express, Inc. (IMXI) after the deal failed to close by the November 10, 2026, outside date. IMXI has disputed the termination, alleging Western Union breached its obligations to obtain regulatory approvals and is reserving its rights to seek specific performance or damages.

Counterparty
The Western Union Company
6:08 AM ET 10-K
Financial Results Ezcorp Inc EZPW ▶ Call

Ezcorp FY 2026 Results: Net Income $166M, Up 51.4% YoY

EZCORP expanded its footprint in 2026 through the acquisition of Founders and SMG, which became a new standalone reportable segment. The company grew its store count to 1,590 locations and reported that pawn service charges accounted for 61% of total gross profit for the fiscal year.

Key figure
Net income $166M · +51.4% YoY
6:08 AM ET 8-K
Financial Results Edgewell Personal Care Co EPC

Edgewell Personal Care Financial Results

Edgewell Personal Care reported fourth quarter net sales of $484.1 million, up 3.1% organically, and adjusted EPS of $0.78. For the full fiscal year 2026, the company achieved net sales of $1.99 billion and provided a fiscal 2027 outlook expecting continued growth in organic net sales and adjusted EBITDA.

Term
FY2026

“Fiscal 2026 was a year of meaningful progress and change for Edgewell, culminating in a strong fourth quarter that reflected continued growth in North America, a return to growth in International and stronger performance across our focus brands.”

Rod Little, President and Chief Executive Officer

“We enter fiscal 2027 as a more focused business, with confidence in our plans to build on this progress, increase support behind our brands and improve profitability.”

Rod Little, President and Chief Executive Officer
6:08 AM ET 8-K
Financial Results EnerSys ENS

EnerSys Financial Results

EnerSys reported second quarter fiscal 2027 results with net sales of $950 million and diluted EPS of $2.42, representing a 34% increase year-over-year. The company highlighted strong demand in data centers and defense applications, which helped offset pressure in material handling. Additionally, the board declared a quarterly cash dividend of $0.2875 per share and noted the pending acquisition of Ultralife.

Term
Q2 2027

“In the second quarter of fiscal year 2027, we delivered gross margin expansion, adjusted operating margin expansion and adjusted EPS growth while continuing to advance our strategic priorities.”

Shawn O’Connell, President and Chief Executive Officer

“We recently announced that we entered into a definitive agreement to acquire Ultralife, which is a compelling strategic fit for EnerSys and directly advances our strategy to build a broader, more differentiated defense power platform.”

Shawn O’Connell, President and Chief Executive Officer
6:08 AM ET 10-Q
Financial Results X-Energy, Inc. XE

X-Energy Q3 2026 Results: Net Loss of $59.4M

X-Energy, Inc. reported a significant increase in total assets to $2.22 billion as of September 30, 2026, driven by a substantial rise in cash and short-term investments following capital raising activities. The company remains in a growth phase, focusing on the Xe-100 reactor design and fuel fabrication facilities while operating as a non-accelerated filer and emerging growth company.

Key figure
Net loss $59.4M
6:08 AM ET Form 4
Insider Buying Ferroglobe PLC GSM

Ferroglobe Insider David Marie Gabriel Girardeau Buys $40.6K of Stock

David Marie Gabriel Girardeau bought 15,500 shares of Ferroglobe PLC at $2.62 a share, worth $40.6K in total on Nov 6, 2026. Shares held after the trade: 70,664 (+28.1%).

Value
$40.6K
Shares
15,500
Price
$2.62
Holding change
+28.1%
Trade date
Nov 6, 2026
6:08 AM ET 8-K
Other 8-K Filing GP-Act III Acquisition Corp. GPAT

GP-Act III Acquisition Other 8-K Filing

GP-Act III Acquisition Corp. entered into non-redemption agreements with investors holding 2,525,000 Class A ordinary shares ahead of a shareholder meeting to extend its business combination deadline. In exchange for agreeing not to redeem their shares and voting in favor of the extension from November 13, 2026, to May 8, 2027, the sponsor will transfer 505,000 existing founder shares to these investors upon the closing of an initial business combination.

6:08 AM ET 8-K
Nasdaq/NYSE Compliance Notice AtlasClear Holdings, Inc. ATCH

AtlasClear Holdings Nasdaq/NYSE Compliance Notice

AtlasClear Holdings received notice from NYSE American that the exchange has suspended trading of its common stock and commenced delisting proceedings due to a low selling price. The company intends to appeal the determination and expects its stock to begin trading on the OTC Pink Limited Market on November 11, 2026.

Counterparty
NYSE American LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.